| Literature DB >> 21359402 |
John Spencer1, Jahangir Amin, Samantha K Callear, Graham J Tizzard, Simon J Coles, Peter Coxhead, Matthew Guille.
Abstract
(E)- and (Z)-3-Ferrocenylmethylidene-1,3-dihydro-2H-indol-2-ones 1 have been structurally modified in order to explore SAR against a range of kinases. Of note is the submicromolar to low micromolar inhibition of DYRK3 and 4 by a number of complexes. Screening using Xenopus embryos showed some of the compounds to have potent antiangiogenisis activity.Entities:
Mesh:
Substances:
Year: 2011 PMID: 21359402 DOI: 10.1039/c1mt00017a
Source DB: PubMed Journal: Metallomics ISSN: 1756-5901 Impact factor: 4.526